Related Experiment Video
Updated: Jul 20, 2026

11:07
Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
Chronic effect of transrectal split-focus ultrasonic ablation on canine prostatic tissue
Kazuaki Sasaki1, Takashi Azuma, Ken-Ichi Kawabata
1Central Research Laboratory, Hitachi, Ltd, Kokubunji, Tokyo, Japan.
The Journal of Veterinary Medical Science
|September 6, 2006
Summary
Split-focus high-intensity focused ultrasound (HIFU) offers a faster, noninvasive treatment for canine prostate cancer. This novel approach effectively ablates prostatic tissue without harming surrounding structures, creating a therapeutic cavity.
Area of Science:
- Veterinary Medicine
- Oncology
- Biomedical Engineering
Background:
- Prostatic cancer treatment in dogs often requires invasive procedures.
- High-intensity focused ultrasound (HIFU) is a promising noninvasive thermal ablation technique.
- The split-focus approach may reduce HIFU treatment times.
Purpose of the Study:
- To evaluate the feasibility of transrectal split-focus HIFU for canine prostatic cancer treatment.
- To assess the efficacy and safety of split-focus HIFU in ablating canine prostatic tissue.
- To determine if split-focus HIFU can ablate prostate tissue without damaging surrounding organs.
Main Methods:
- A prototype 4.2-MHz split-focus therapeutic transducer and 6.5-MHz imaging probe were used.
- Transrectal HIFU ablation was performed on 5 dogs' prostates under B-mode ultrasound guidance.
- Treatment involved 4 shots at 1.7 kW/cm(2) for 4 seconds each.
Main Results:
- Prostates became stiff post-treatment due to thermal effects.
- Dogs recovered normal urination within a week, with antibiotic prophylaxis.
- A centrally located cystic cavity (0.34–0.45 cm(3)) formed within two weeks.
- Necropsy at three months showed no gross or histological damage to the rectum or prostate capsule.
Conclusions:
- Split-focus transrectal HIFU is a feasible noninvasive treatment for canine prostatic cancer.
- This method effectively ablates prostatic parenchyma while preserving surrounding tissues.
- Further research may establish split-focus HIFU as a viable therapeutic option for canine prostate cancer.

